Annual revenue:
$160.18M-$34.44M(-17.70%)Summary
- As of today (June 27, 2025), AKBA annual revenue is $160.18 million, with the most recent change of -$34.44 million (-17.70%) on December 31, 2024.
- During the last 3 years, AKBA annual revenue has fallen by -$51.47 million (-24.32%).
- AKBA annual revenue is now -52.19% below its all-time high of $335.00 million, reached on December 31, 2019.
Performance
AKBA Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$57.34M+$10.84M(+23.31%)Summary
- As of today (June 27, 2025), AKBA quarterly revenue is $57.34 million, with the most recent change of +$10.84 million (+23.31%) on March 31, 2025.
- Over the past year, AKBA quarterly revenue has increased by +$24.73 million (+75.84%).
- AKBA quarterly revenue is now -54.63% below its all-time high of $126.36 million, reached on June 30, 2022.
Performance
AKBA Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$184.91M+$24.73M(+15.44%)Summary
- As of today (June 27, 2025), AKBA TTM revenue is $184.91 million, with the most recent change of +$24.73 million (+15.44%) on March 31, 2025.
- Over the past year, AKBA TTM revenue has dropped by -$2.32 million (-1.24%).
- AKBA TTM revenue is now -47.29% below its all-time high of $350.81 million, reached on March 31, 2020.
Performance
AKBA TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
AKBA Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.7% | +75.8% | -1.2% |
| 3 y3 years | -24.3% | -7.1% | -16.4% |
| 5 y5 years | -52.2% | -35.2% | -47.3% |
AKBA Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -45.2% | at low | -54.6% | +75.8% | -37.2% | +15.4% |
| 5 y | 5-year | -52.2% | at low | -54.6% | +75.8% | -47.3% | +15.4% |
| alltime | all time | -52.2% | >+9999.0% | -54.6% | +3635.2% | -47.3% | >+9999.0% |
AKBA Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $57.34M(+23.3%) | $184.91M(+15.4%) |
| Dec 2024 | $160.18M(-17.7%) | $46.50M(+24.2%) | $160.18M(-5.7%) |
| Sep 2024 | - | $37.43M(-14.3%) | $169.88M(-2.6%) |
| Jun 2024 | - | $43.65M(+33.9%) | $174.50M(-6.8%) |
| Mar 2024 | - | $32.61M(-42.0%) | $187.22M(-3.8%) |
| Dec 2023 | $194.62M(-33.5%) | $56.20M(+33.7%) | $194.62M(+0.2%) |
| Sep 2023 | - | $42.05M(-25.4%) | $194.21M(-3.3%) |
| Jun 2023 | - | $56.38M(+40.9%) | $200.88M(-25.8%) |
| Mar 2023 | - | $40.01M(-28.3%) | $270.87M(-7.4%) |
| Dec 2022 | $292.48M(+38.2%) | $55.78M(+14.5%) | $292.56M(-0.6%) |
| Sep 2022 | - | $48.71M(-61.4%) | $294.45M(-0.0%) |
| Jun 2022 | - | $126.36M(+104.8%) | $294.50M(+33.2%) |
| Mar 2022 | - | $61.70M(+7.0%) | $221.04M(+4.4%) |
| Dec 2021 | $211.65M(-28.2%) | $57.68M(+18.3%) | $211.65M(+0.8%) |
| Sep 2021 | - | $48.76M(-7.9%) | $210.01M(-5.1%) |
| Jun 2021 | - | $52.91M(+1.2%) | $221.24M(-14.4%) |
| Mar 2021 | - | $52.30M(-6.7%) | $258.47M(-12.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $294.64M(-12.0%) | $56.04M(-6.6%) | $294.64M(-4.4%) |
| Sep 2020 | - | $59.99M(-33.5%) | $308.16M(-9.4%) |
| Jun 2020 | - | $90.14M(+1.9%) | $340.15M(-3.0%) |
| Mar 2020 | - | $88.48M(+27.2%) | $350.81M(+4.7%) |
| Dec 2019 | $335.00M(+61.3%) | $69.56M(-24.4%) | $335.00M(+3.0%) |
| Sep 2019 | - | $91.98M(-8.8%) | $325.30M(+13.5%) |
| Jun 2019 | - | $100.80M(+38.7%) | $286.49M(+22.2%) |
| Mar 2019 | - | $72.67M(+21.4%) | $234.48M(+12.9%) |
| Dec 2018 | $207.74M(+14.6%) | $59.85M(+12.6%) | $207.74M(-12.9%) |
| Sep 2018 | - | $53.17M(+9.0%) | $238.45M(+5.2%) |
| Jun 2018 | - | $48.79M(+6.2%) | $226.56M(+9.8%) |
| Mar 2018 | - | $45.93M(-49.3%) | $206.29M(+13.8%) |
| Dec 2017 | $181.23M(>+9900.0%) | $90.56M(+119.4%) | $181.23M(+96.6%) |
| Sep 2017 | - | $41.28M(+44.8%) | $92.20M(+81.1%) |
| Jun 2017 | - | $28.52M(+36.7%) | $50.92M(+127.3%) |
| Mar 2017 | - | $20.86M(+1259.3%) | $22.40M(+1359.3%) |
| Dec 2016 | $1.53M | $1.53M | $1.53M |
FAQ
- What is Akebia Therapeutics annual revenue?
- What is the all time high annual revenue for Akebia Therapeutics?
- What is Akebia Therapeutics annual revenue year-on-year change?
- What is Akebia Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly revenue year-on-year change?
- What is Akebia Therapeutics TTM revenue?
- What is the all time high TTM revenue for Akebia Therapeutics?
- What is Akebia Therapeutics TTM revenue year-on-year change?
What is Akebia Therapeutics annual revenue?
The current annual revenue of AKBA is $160.18M
What is the all time high annual revenue for Akebia Therapeutics?
Akebia Therapeutics all-time high annual revenue is $335.00M
What is Akebia Therapeutics annual revenue year-on-year change?
Over the past year, AKBA annual revenue has changed by -$34.44M (-17.70%)
What is Akebia Therapeutics quarterly revenue?
The current quarterly revenue of AKBA is $57.34M
What is the all time high quarterly revenue for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly revenue is $126.36M
What is Akebia Therapeutics quarterly revenue year-on-year change?
Over the past year, AKBA quarterly revenue has changed by +$24.73M (+75.84%)
What is Akebia Therapeutics TTM revenue?
The current TTM revenue of AKBA is $184.91M
What is the all time high TTM revenue for Akebia Therapeutics?
Akebia Therapeutics all-time high TTM revenue is $350.81M
What is Akebia Therapeutics TTM revenue year-on-year change?
Over the past year, AKBA TTM revenue has changed by -$2.32M (-1.24%)